NEW YORK (GenomeWeb) – Wafergen Biosystems today announced a collaboration with a unit of the University of Toronto for the use of the company's sample preparation technology for affordable and large-scale BRCA1 and BRCA2 screening. 

The agreement is with the Familial Breast Cancer Research Unit of the Women's College Research Institute at the University of Toronto for the use of Wafergen's Seq-Ready TE System. Steven Narod, director of the Familial Breast Cancer Research Unit and Mohammad Akbari, an assistant professor at the university, will lead the research. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.